demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
Lopinavir/ritonavir plus hydroxychloroquine REMAP-CAP ...

0 studies excluded by filtering options 0